We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Poolbeg Pharma Plc | LSE:POLB | London | Ordinary Share | GB00BKPG7Z60 | ORD 0.02P |
| Price Change | % Change | Share Price | Shares Traded | Last Trade
|
|
|---|---|---|---|---|---|
| 0.35 | 3.43% | 10.55 | 1,234,160 | 15:20:52 |
| Bid Price | Offer Price | High Price | Low Price | Open Price | |
|---|---|---|---|---|---|
| 10.40 | 10.70 | 10.55 | 10.20 | 10.20 | |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Coml Physical, Biologcl Resh | -4.69M | -0.0094 | -11.22 | 52.75M |
| Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
|---|---|---|---|---|
| 17:06:46 | O | 90,000 | 10.55 | GBX |
| Date | Time | Source | Headline |
|---|---|---|---|
| 20/3/2024 | 16:18 | ALNC |  EARNINGS AND TRADING: Roadside Real Estate trims Cambridge Sleep stake |
| 20/3/2024 | 07:00 | UK RNS | Poolbeg Pharma PLC POLB 001 US Patent Update |
| 22/2/2024 | 07:00 | UK RNS | Poolbeg Pharma PLC Director/PDMR Shareholding |
| 19/2/2024 | 13:42 | UK RNS | Poolbeg Pharma PLC Director Share Purchase |
| 15/2/2024 | 16:02 | ALNC | TRADING UPDATES: Diversified Energy offers dividend alternative |
| 15/2/2024 | 07:00 | UK RNS | Poolbeg Pharma PLC Board Role Change and Launch of EIP |
| 12/2/2024 | 19:44 | ALNC | TRADING UPDATES: Katoro Gold launches fundraising, eyes board shake-up |
| 12/2/2024 | 07:00 | UK RNS | Poolbeg Pharma PLC Market Opportunity for POLB 001 for CRS |
| 17/1/2024 | 13:58 | ALNC | Poolbeg Pharma hails POLB 001'S potential to treat CRS |
| 17/1/2024 | 07:00 | UKREG | Poolbeg Pharma PLC Further data shows POLB001 potential in cancer CRS |
Poolbeg Pharma (POLB) Share Charts1 Year Poolbeg Pharma Chart |
|
1 Month Poolbeg Pharma Chart |
Intraday Poolbeg Pharma Chart |
| Date | Time | Title | Posts |
|---|---|---|---|
| 19/4/2024 | 14:33 | Poolbeg Pharma | 3,111 |
| 24/10/2022 | 16:20 | Polb | 1 |
| Trade Time | Trade Price | Trade Size | Trade Value | Trade Type |
|---|---|---|---|---|
| 2024-04-23 16:06:46 | 10.55 | 90,000 | 9,495.00 | O |
| 2024-04-23 15:29:22 | 10.50 | 100,000 | 10,500.00 | O |
| 2024-04-23 15:29:15 | 10.42 | 100,000 | 10,420.00 | O |
| 2024-04-23 15:28:21 | 10.50 | 165,000 | 17,325.00 | O |
| 2024-04-23 15:22:04 | 10.44 | 122,609 | 12,797.31 | O |
| Top Posts |
|---|
Posted at 23/4/2024 09:20 by Poolbeg Pharma Daily Update Poolbeg Pharma Plc is listed in the Coml Physical, Biologcl Resh sector of the London Stock Exchange with ticker POLB. The last closing price for Poolbeg Pharma was 10.20p.Poolbeg Pharma currently has 500,000,000 shares in issue. The market capitalisation of Poolbeg Pharma is £52,750,000. Poolbeg Pharma has a price to earnings ratio (PE ratio) of -11.22. This morning POLB shares opened at 10.20p |
Posted at 20/3/2024 07:56 by burtond1 ??????????? RNS this for @PoolbegPharma Notice of Allowance for Significant POLB 001 Patent in United States"...I am excited by the potential of POLB 001 to positively impact global health..."#POLB CEO Jeremy Skillingtonhttps://w |
Posted at 11/3/2024 15:10 by sikhthetech Supernumerary,Polb is all talk, jam tomorrow. TLY announced yet another contract today... you must be even more dismayed than before... IIs increasing and now more contracts... Plus it's in Republic of Ireland!!. Which confirms you're clueless, given you believe TLY has only 1 customer... Republic of Ireland is NOT part of NHS or even the UK... Clueless. As to holding several shares. You mean like yours, 1gw and the blnx gang. Byot, down 95% Nexn, ex blnx, ex trmr, ex rthm (so many changes) down 80-90% depending on which iteration of name change you choose. Nano, down 60% etc etc Polb still around IPO share price after years of talking. HVO still below the 45p peak of years gone past and where the founder/Chairman dumped majority of his holding. That's quite an appalling history of failures for someone who portray themselves as well researched, isn't it?. :-) |
Posted at 22/2/2024 16:25 by troutisout He can't really win can he? He sells some HVO placed with IIs and people want him to buy more POLB, he and the CEO do and now the drop is his fault. Just remind me where the share price was a week ago? We are still above that, but traders took us up and now traders have brought us back down again....Not really CF's fault...Just like HVO, POLB will do very well, in the medium to long term they could both give huge returns, but it won't all be in a straight line. |
Posted at 15/2/2024 11:07 by 1gw parsons4 - well if we take CF's relatively recent linkedin post at face value (and I know some don't) about aiming to complete the IPO of POLB on Nasdaq later this year then I can understand his desire to get the share price up ahead of setting the price for that.If I were then to look at even more recent discussion of acquiring and commercialising rare/orphan disease drugs, I might start to think that there could be a plan to acquire or reverse in to an existing Nasdaq-quoted company that was low on cash but had some promising approved or late phase drugs, particularly if those drugs were in the oncology space that would fit with trials of POLB001 for immunotherapy-induce Whether IPO'ing directly as POLB, or raising cash following, or as part of, an acquisition/reverse, a high shareprice would be a lot more useful than a low shareprice in terms of minimising the dilution of existing shareholders. |
Posted at 15/2/2024 10:05 by lfdkmp Surprised nobody has commented on (from today's RNS) :"... with vesting conditional upon the weighted-average of the mid-market closing price of the ordinary shares in the Company being 17.945 pence or above over a period of fourteen calendar days (representing a c.85% premium to the share price at close of market on February 14, 2024)." Maybe an indication of management's expectations of share price in medium term? (as it stands today, not exactly a gimme ) |
Posted at 12/2/2024 09:16 by burtond1 Massive opportunity this for #POLB https://www.londonst |
Posted at 07/2/2024 23:27 by troutisout 50% of the share issue of POLB was owned by the shareholders of HVO, many sold their POLB shares many doubled down and bought more. I try and buy a bit of both every month to average in to a large holding, but some times when there is a disparity I favour the underdog and it seems to have worked up to now...I am sure there may be a slight correlation to other pharma stocks, but not as closely aligned as these two are. I have seen others mention profits from one flowing into the other on these BBs if others are thinking that then perhaps there is something to that? Pink lines show when POLB got ahead of HVO and when it caught up, green lines when HVO went ahead of POLB. It's a pattern that has happened many times and so unlikely to be just pure coincidence. free stock charts from uk.advfn.com |
Posted at 07/2/2024 18:54 by troutisout We have all seen the great rise in HVO over the last 7 months, starting with contract wins in late June and July, then the positive trading update at the end of July and of course, what was the start of Institutional buying.Before that POLB mirrored HVO quite closely, deviating a little every now and then and then one or the other adjusting back. POLB showed the way in late Summer/Autumn 2022 with HVO mirroring the moves several weeks later. Then HVO leapt ahead of POLB in the late Summer/Autumn 2023, but the news of the Amryt team joining propelled POLB back up there again in November. As we went into the Christmas period and the New Year HVO has hit the rocket boosters with more contract wins and a really good TU. POLB has dithered and dropped slightly. I don't think the relationship between the two has broken (although the II buying in HVO will have diluted the relationship where many of the holders of HVO also held POLB). So we wait to see if POLB catches up again, it certainly looks a few weeks behind but the correlation has been strong up to now.... POLB black, HVO Blue, HVO overlaid on POLB from the first day of POLB trading free stock charts from uk.advfn.com |
Posted at 26/1/2024 07:48 by troutisout Klosters whether you think I am besotted or not, I have been saying as much at HVO for 8 months and it has been backed up by II holdings in that period. Here at POLB there looks to be some large buying at times, so could well be some larger buyers, however after every rise the share price gets pulled back down and often before the volume of sells to justify any drops, the price is leading the selling, who quotes the prices? Who sells all the shares to buyers in a rise? Who needs to eventually balance their books?As for IIs they do buy at lower prices than retail because they have the clout to, if the order is large enough then you can put a limit buy in below the market and watch the share price migrate to that price and the order get filled before then moving back up again. Or do you believe this is a fair and even system? |
Posted at 07/12/2023 16:06 by spuddymadrid Hello there Chica. How are things. I was an original shareholder at Fastnet and bought at around 3p which was consolidated in a 1 for 8 into Amryt to give 24 pence a share. This was then converted into a 1 for 6 upon Algerion merger to give 144 pence. ANd finally the conversion of the ADRs was 1 for 5 to give 720 pence at a vonversion rate of 0.82 to give 878 cents. Sold the shares for 1450 cents. So approximately a 56% gain. And you are correct not a windfall. I did not like the fact either that growth came on the back of the dillution of shareholders. However I believe that Amryt and Poolbeg are different. We have a number of potential deals that will move the share price by a major amount Any of these deals could double share price whilst also bringing in cash. Amryt started with a small cash position (residual monies from fastnet).Any funds raised were used to by Episalvan and AP-102. Before a deal was done on Lujuxta Amryt had already spend 10m of a 20m loan facility from the EIB with no revenue in sight. So it was starting from a weaker base. Poolbeg will do very well in my opinion. We have cash in the bank. No debt. Potential important deals on the way. I understand your pessimism which I consider a good thing. If I had more of it I would have saved myself from getting burnt on occasions. But I believe that Poolbeg is a gem and I think we will do very well even though at times it reuires the patience of JOB |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
